In-vitro Diagnostics--Industry Impact (Technical Insights)

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service analyzes emerging technologies in the field of invitro diagnostics and their impact in the healthcare market

Table of Contents

In-vitro Diagnostics--Industry Impact (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologyKey FindingsNoteworthy Emerging TechnologiesNoteworthy ApplicationsIn-vitro Diagnostics--Industry Impact (Technical Insights), Technology and Applications ViewpointTechnology PrimerDNA MicroarrayPolymerase Chain Reaction (PCR)ImmunoassaysTechnology and Applications AnalysisApplication Analysis and TrendsTechnology RoadmapAssessment of Stakeholder Innovation in Companies and UniversitiesNoteworthy Innovation at Key CompaniesNoteworthy Innovation at Key Academic and Government-Related InstitutionsInfluential Market FactorsMergers and AcquisitionsRegulatory/Reimbursement Issues Industry Trends and FutureIn-vitro Diagnostics--Industry Impact (Technical Insights), Technology Adoption Factor AnalysisKey ChallengesMarket NeedsTechnologyCommercializationEducation/Training Key Drivers and RestraintsDriversRestraintsIn-vitro Diagnostics--Industry Impact (Technical Insights), Assessment of Innovation and OpportunitiesInnovative Development in Companies (North America)Bayer Continues To Broaden Assay MenusBiomerieux's New Generation Platform for Isolation of Nucleic Acids Oral-Fluid Based Testing for Drugs of Abuse by AvitarBioMerieux's Latest Offering for Bacterial Identification and Antibiotic Susceptibility TestingFirst-ever Instant Testing Device for AnemiaCiphergen's SELDI Technology as a Diagnostic PlatformDade Behring's New Generation Integrated System for Clinical LaboratoriesNew Screening Tool for Point-of-care Detection of Diabetes and Pre-DiabetesAbbott's Latest Offering for HematologyCaliper's LabChip Technology for Diagnostic ApplicationsICT's Whole-cell Protease Kits for Cancer and Neurogenerative Diseases DetectionFirst Blood Test for Mesothelioma from FDIVeridex's Focus On Cancer DiagnosticsSideKick--the World's Smallest Diabetes SystemAbaxis' Clinical Chemistry System for PoC TestingCeMines Focus on Biomarkers for Detecting CancerInnovative Development in Companies (Europe/APAC)Roche's HPV Genotyping Test for Cervical CancerHemocue's PoC system for Testing Glucose and HemoglobinA New Test to Assess Osteoporosis-Related Fracture RiskDiaGenic's Microarray Platform for Diagnosis of Breast Cancer and Alzheimer'sGreiner Bio-One's Kit for Detection of Periodontal PathogensSyft Technologies' Novel Instrument for Diagnostic SolutionsInnovative Developments in UniversitiesHandheld Diagnostic Device for Detection of Gum and Heart DiseaseBio-Barcode Amplification Technology for Detection of Cancer and Infectious DiseasesNanowire Detectors with Key Applications in DiagnosticsInterferon-Gamma Assays for Diagnosis of Latent TuberculosisSpanish University Unveils a Unique Portable Diagnostic ToolIn-vitro Diagnostics--Industry Impact (Technical Insights), Patents; Contacts and GlossaryPatentsPatents 1Patents 2Patents 3Contacts and GlossaryContactsGlossaryIn-vitro Diagnostics--Industry Impact (Technical Insights), Frost & Sullivan 2005 Science and Technology AwardsProduct Innovation AwardAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientIn-vitro Diagnostics--Industry Impact (Technical Insights), Critical Reference TablesDecision Support Database TablesDiabetes Prevalence (1999-2006)HIV Prevalence (1999-2006)AIDS Mortality (1999-2006)HIB Immunization (1999-2006)Breast Cancer Incidence (1999-2006)Breast Cancer Mortality (1999-2006)Prevalence of Alzheimer's Disease (1999-2006)Alzheimer Disease's Mortality (1999-2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.